TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Almirall ( (ES:ALM) ) has shared an announcement.
Almirall has announced the divestment of its product Algidol® and the licensing of Sekisan® in Spain, receiving €12 million upfront and additional future payments. This move is part of Almirall’s strategy for portfolio rotation and management, potentially streamlining its focus and enhancing financial flexibility.
More about Almirall
Almirall is a pharmaceutical company focusing on the development and marketing of medical products. The company specializes in dermatology and other therapeutic areas, providing treatments for a variety of health conditions.
YTD Price Performance: 17.08%
Average Trading Volume: 3,882
Technical Sentiment Consensus Rating: Sell
Current Market Cap: €2.03B
See more insights into ALM stock on TipRanks’ Stock Analysis page.